2021/1 GaBI Journal Table of Contents

Contents

Editor’s Letter

First 2021 GaBI Journal issue highlights

Original Research

Biosimilars – status in July 2020 in 16 countries

An assessment of trends in the Iranian pharmaceutical market following domestic production of selected medications (2007‒2017) and new considerations for health policymakers

Review Article

Continuous manufacturing versus batch manufacturing: benefits, opportunities and challenges for manufacturers and regulators

Source URL: https://gabi-journal.net/2021-1-gabi-journal-table-of-contents.html